Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids

TNF signalling was reported to mediate resistance to EGFR inhibition in non-small cell lung cancer (NSCLC). Here, the authors examine the efficacy of a broad versus focused targeting of this resistance, and they show that a broad inhibitor of inflammation, prednisone is the most effective.

Guardado en:
Detalles Bibliográficos
Autores principales: Ke Gong, Gao Guo, Nicole A. Beckley, Xiaoyao Yang, Yue Zhang, David E. Gerber, John D. Minna, Sandeep Burma, Dawen Zhao, Esra A. Akbay, Amyn A. Habib
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/8990fc56283d450e992bf4f9c8feb77b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8990fc56283d450e992bf4f9c8feb77b
record_format dspace
spelling oai:doaj.org-article:8990fc56283d450e992bf4f9c8feb77b2021-12-05T12:22:21ZComprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids10.1038/s41467-021-27276-72041-1723https://doaj.org/article/8990fc56283d450e992bf4f9c8feb77b2021-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-27276-7https://doaj.org/toc/2041-1723TNF signalling was reported to mediate resistance to EGFR inhibition in non-small cell lung cancer (NSCLC). Here, the authors examine the efficacy of a broad versus focused targeting of this resistance, and they show that a broad inhibitor of inflammation, prednisone is the most effective.Ke GongGao GuoNicole A. BeckleyXiaoyao YangYue ZhangDavid E. GerberJohn D. MinnaSandeep BurmaDawen ZhaoEsra A. AkbayAmyn A. HabibNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Ke Gong
Gao Guo
Nicole A. Beckley
Xiaoyao Yang
Yue Zhang
David E. Gerber
John D. Minna
Sandeep Burma
Dawen Zhao
Esra A. Akbay
Amyn A. Habib
Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
description TNF signalling was reported to mediate resistance to EGFR inhibition in non-small cell lung cancer (NSCLC). Here, the authors examine the efficacy of a broad versus focused targeting of this resistance, and they show that a broad inhibitor of inflammation, prednisone is the most effective.
format article
author Ke Gong
Gao Guo
Nicole A. Beckley
Xiaoyao Yang
Yue Zhang
David E. Gerber
John D. Minna
Sandeep Burma
Dawen Zhao
Esra A. Akbay
Amyn A. Habib
author_facet Ke Gong
Gao Guo
Nicole A. Beckley
Xiaoyao Yang
Yue Zhang
David E. Gerber
John D. Minna
Sandeep Burma
Dawen Zhao
Esra A. Akbay
Amyn A. Habib
author_sort Ke Gong
title Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
title_short Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
title_full Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
title_fullStr Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
title_full_unstemmed Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
title_sort comprehensive targeting of resistance to inhibition of rtk signaling pathways by using glucocorticoids
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8990fc56283d450e992bf4f9c8feb77b
work_keys_str_mv AT kegong comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT gaoguo comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT nicoleabeckley comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT xiaoyaoyang comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT yuezhang comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT davidegerber comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT johndminna comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT sandeepburma comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT dawenzhao comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT esraaakbay comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
AT amynahabib comprehensivetargetingofresistancetoinhibitionofrtksignalingpathwaysbyusingglucocorticoids
_version_ 1718372027811758080